Giving interim relief to pharmaceutical companies, the Delhi High Court on Tuesday decided to hear the matter on March 28.
The high court had earlier stayed the Centre's notification banning drugs manufactured by Abbott India and Macleods Pharma till Monday.
The government had banned 344 drug combinations over the weekend, including Abbott's codeine-based cough syrup, after a government panel found they had 'no therapeutic justification'.
